CBIO
CBIO
NASDAQ · Biotechnology

Crescent Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$18.76
+0.76 (+4.22%)
As of May 9, 9:42 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +47.4% upside
Low Target $15.31
Average Target $27.66
High Target $30.74
Current Price $18.76
Current
$18.76
Target
$27.66
$15.31 $27.66 avg $30.74
Scenario Analysis
Bear Case
$15.31
-18.4%
Low target
Base Case
$27.66
+47.4%
Avg target
Bull Case
$30.74
+63.9%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$28.00
-33.0% from high
52-Week Low
$8.72
+115.1% from low
Target vs 52W High
$27.66
-1.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%